Ligandrol (LGD-4033)
Available in 10mg Tablets (100 Count Bottle)
$100.00
Ligandrol (LGD-4033)
Available in 10mg Tablets (100 Count Bottle)
The Potent Selective Anabolic | Lean Tissue Hypertrophy & Strength Modulator
The 4Balance Codex: The Hypertrophic Specialist. A highly bioavailable, non-steroidal Selective Androgen Receptor Modulator (SARM) distinguished by its exceptional affinity for muscle and bone receptors. It drives significant, dose-dependent increases in lean body mass and functional strength in research models with reduced systemic androgenic activity.
Product Overview
Ligandrol (LGD-4033, also known as VK5211) is widely considered in scientific literature to be among the most potent orally active SARMs developed to date. Originally designed to treat conditions like muscle wasting (cachexia) and age-related muscle loss (sarcopenia), it has demonstrated profound anabolic effects in clinical settings.
Unlike non-selective androgens that affect the entire body, Ligandrol is engineered to target skeletal muscle and bone specifically. 4Balance Peptides offers this powerful research agent in precise, laboratory-grade 10mg tablets. This solid format ensures exacting dosage control for sophisticated research protocols, superior to the variability often found in liquid preparations.
Mechanism of Action: High-Affinity Tissue Selectivity
Ligandrol’s value in research stems from its unique binding profile and its documented effects in human clinical trials:
Extreme Androgen Receptor Affinity: LGD-4033 binds to the androgen receptor (AR) with incredibly high affinity (Ki of ~1 nM). It acts as a full agonist in muscle and bone tissues, stimulating potent anabolic signaling pathways.
Dose-Dependent Lean Mass Gains: Research, including the seminal Phase I trial published in the Journals of Gerontology, demonstrated that LGD-4033 produced statistically significant, dose-dependent increases in lean body mass (LBM) and leg press strength in healthy men over a 21-day period, without significant adverse events.
Tissue Selectivity (Prostate Sparing): While highly highly anabolic in muscle, research models indicate Ligandrol has significantly reduced androgenic activity in the prostate and sebaceous glands compared to testosterone, offering a favorable safety profile for research into long-term anabolic therapy.
Bone Density & Turnover: LGD-4033 signaling in bone tissue increases bone formation rate and bone mineral density, making it a key compound in osteoporosis recovery research.
Primary Research Applications
In the 4Balance Research Array, Ligandrol is the definitive agent for studies focused on maximal tissue accrual and functional strength recovery:
Sarcopenia & Frailty: Investigating its ability to rapidly restore muscle mass and physical function in aging populations.
Cachexia & Wasting Syndromes: Studying its efficacy in counteracting severe catabolic states associated with chronic illnesses (e.g., cancer, COPD).
Post-Surgical Rehabilitation: Researching its role in accelerating recovery of strength and mobility following major orthopedic procedures, such as hip fracture surgery.
Bone Health: Exploring its dual action on both muscle strength and bone density to prevent falls and fractures.
Technical Specifications
Compound Name: Ligandrol (LGD-4033 / VK5211)
Format: Oral Tablets
Concentration: 10mg per Tablet
Quantity: 100 Tablets
Purity: ≥99% (HPLC Verified)
Bioavailability: High Oral Bioavailability
Storage: Store at room temperature, away from direct light and moisture.
DISCLAIMER: FOR LABORATORY RESEARCH USE ONLY. This product is a laboratory chemical intended strictly for in-vitro and in-vivo research and development. It is not a drug, dietary supplement, or treatment for any medical condition. NOT for human consumption, veterinary use, or therapeutic application. Bodily introduction of any kind is strictly prohibited by law. Buyer assumes all responsibility for applicable regulations and appropriate use in a research setting.
